IRIDEX proclaimed that it has received a patent from the US Patent and Trademark Office for a portfolio of uniquely developed laser handpieces utilized in invasive ophthalmic surgeries.
The new patent’s number is 7,909,816 and titled as ‘Directional Probe Treatment Apparatus. It covers IRIDEX’s portfolio of several consumable medical instruments known as Stepped Angled EndoProbe laser handpieces. A part of the outside diameter in these medical devices has been reduced in size and modified into an arc. These added features in one equipment provides ophthalmologists the medical advantages of a curved laser probe, while sustaining usability with the straight cannulas utilized with the latest small-gauge vitrectomy devices.
The design of the proprietary Stepped Angled EndoProbe handpiece provides certain specific benefits over standard angled probes. The handpieces are long-lasting and equipped to withstand the severity of invasive laser surgery, while concurrently offering laser power that feature less deviation with constantly higher irradiance and lower divergence. IRIDEX produces the handpieces in 25, 23 and 20 gauges.
The President and Chief Executive Officer at IRIDEX, Theodore A. Boutacoff stated that the issuance of new patent for the Stepped Angled probes is significant for the company. Users are happy with the long-lasting, user-friendly, high performance probes. He further said that the company has plans to expand its Stepped Angled EndoProbe portfolio by launching new versions.